TNF and deep vein thrombosis: Compared with TNF inhibitors, the HRs (95% CI) for DVT and PE were 1.66 (0.60–4.57) and 2.99 (0.81–11.06) with tofacitinib 5 mg twice daily and 2.13 (0.80–5.69) and 5.96 (1.75–20.33) with tofacitinib 10 mg twice daily, respectively.